Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Aruna Bio to Present at the 31st Annual Piper Jaffray Healthcare Conference

Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced that Dr. Mark Sirgo, Chief Executive Officer, and Dr. Steve Stice, Chief Scientific Officer, will be presenting at the 31st Annual Piper Jaffray Healthcare Conference in New York City on Thursday, December 5th at a new time of 9:30 AM Eastern Time.

The presentation will be webcast live and available on the events page of the Aruna Bio website (arunabio.com/events) and via the link below. A replay of the webcast will be available following the conference at arunabio.com/events.

Date: Thursday, December 5, 2019
Time: 9:30 AM Eastern Time
Webcast: https://event.webcasts.com/starthere.jsp?ei=1271874&tp_key=4093b6fa98

Drs. Sirgo and Stice will discuss the utilization of neural exosomes as both a therapeutic and a delivery vehicle to treat neurodegenerative diseases and stroke. The presentation will include data on Aruna Bio's proprietary neural exosome platform, which has demonstrated therapeutic benefit in multiple animal models of stroke and is also being developed for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Dr. Sirgo will also discuss the company's going forward strategy and key milestones for 2020.

About Aruna Bio
Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body's anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. Aruna Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules. www.arunabio.com

These press releases may also interest you

at 02:28
Sivers IMA Holding AB today announces the launch of the new state-of-art 5G mmWave Dual Quad Beamformer IC's (BFIC) to be used in several 5G applications. These BFIC's are the result of a joint development project between Ampleon Netherlands B.V...

at 02:25
Foresight Autonomous Holdings Ltd. , an innovator in automotive vision systems, announced today an additional sale of a prototype of its QuadSight® four-camera vision system targeted for the semi-autonomous and autonomous vehicle market. The...

at 02:25
Mycronic AB (publ) has received an order for the new SLX mask writer from a customer in Asia. The customer already has mask writers from Mycronic. The order value for the chosen SLX configuration is between USD 3 and 4 million. Delivery is scheduled...

at 02:24
The coronavirus outbreak in China has led to the country's primary and secondary school students completing the unusual first lesson of the new school year online as internet + education has become the preferred choice of learning during these...

at 02:10
ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, today released its SuperDSS solution, the industry's unique solution for tri-RAT...

at 02:05
PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company") today announced that Daphne Zohar, founder and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York on Tuesday, February 25, at 9:00...

News published on 21 november 2019 at 07:05 and distributed by: